Literature DB >> 14732354

TLK1B is elevated with eIF4E overexpression in breast cancer.

Kathryn S Norton1, Derek McClusky, Siddhartha Sen, Herbert Yu, Carol Meschonat, Arrigo Debenedetti, Benjamin D L Li.   

Abstract

INTRODUCTION: The overexpression of eukaryotic initiation factor 4E (eIF4E), a critical component of the "RNA helicase" necessary for the initiation of protein synthesis of mRNAs with long 5' prime untranslated regions (5'UTRs), can result in malignant transformation. In a prospective study on breast cancer outcome of women with stage I to III disease, eIF4E overexpression was an independent predictor of cancer recurrence (RR = 7.3, CI = 1.58-33.9). Dysregulation of Tousled-like kinase 1B (TLK1B), a threonine kinase with a highly conserved gene sequence, has been linked to defects in cell division and DNA replication. In cell lines, TLK1B overexpression has been recently associated with resistance to radiation. The 5'UTR of TLK1B is long (1088 nt) and the structure is complex. Our hypothesis is that TLK1B elevation is correlated with the overexpression of eIF4E in human breast carcinoma.
MATERIAL AND METHODS: Eighty-seven patients with invasive breast cancer and 11 patients with benign breast disease were accrued prospectively. Clinical data collected include age, race, stage, grade of tumor, ER, and PR status. TLK1B and eIF4E levels were quantified by Western blot analysis. Statistical analysis was performed using Spearman correlation, paired and unpaired t test, and multivariate analysis.
RESULTS: In the 87 cancer specimens from patients with breast carcinoma, eIF4E level was elevated by a mean of 9.5-fold (range = 1.8-48.4), and TLK1B was elevated by a mean of 9.4-fold (range = 1.0-58.0) when compared to the 11 specimens from noncancer patients. Multivariate analysis performed demonstrates the degree of eIF4E overexpression is independent of age, race, tumor grade, and ER or PR status of the tumor. Similarly, the degree of TLK1B elevation is independent of age, tumor grade, and ER or PR status of the tumor. Using the Spearman correlation, the degree of TLK1B elevation was strongly correlated with the degree of eIF4E overexpression (r = 0.39, P = 0.001).
CONCLUSIONS: Both eIF4E and TLK1B are elevated in breast cancer specimens but not in benign breast specimens from noncancer patients. The degree of TLK1B elevation is correlated with the degree of IF4E overexpression. Both eIF4E and TLK1B overexpression are independent of tumor grade, tumor stage, and ER and PR status.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732354     DOI: 10.1016/j.jss.2003.08.001

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.

Authors:  Shousen Hu; Honghan Wang; Dan Yan; Wuhao Lu; Pei Gao; Weihua Lou; Xiangzhen Kong
Journal:  Cell Cycle       Date:  2018-10-09       Impact factor: 4.534

2.  Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting.

Authors:  Yu Xiang Fang; Xiao Bo Zhang; Wei Wei; Yi Wen Liu; Jin Zhong Chen; Jing Lun Xue; Ling Tian
Journal:  Mol Biotechnol       Date:  2010-05       Impact factor: 2.695

3.  The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks.

Authors:  Gulshan Sunavala-Dossabhoy; Sri Kripa Balakrishnan; Siddhartha Sen; Sam Nuthalapaty; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2005-09-12       Impact factor: 2.946

4.  TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1.

Authors:  Siddhartha P Sen; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2006-10-20       Impact factor: 2.946

5.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

6.  Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.

Authors:  Md Imtiaz Khalil; Christopher Madere; Ishita Ghosh; Rosalyn M Adam; Arrigo De Benedetti
Journal:  Pathophysiology       Date:  2021-07-20

Review 7.  Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance.

Authors:  Md Imtiaz Khalil; Arrigo De Benedetti
Journal:  Cancer Drug Resist       Date:  2022-01-19

8.  Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.

Authors:  Heather E Kleiner; Prasad Krishnan; Jesse Tubbs; Mark Smith; Carol Meschonat; Runhua Shi; Mary Lowery-Nordberg; Patrick Adegboyega; Marcia Unger; James Cardelli; Quyen Chu; J Michael Mathis; John Clifford; Arrigo De Benedetti; Benjamin D L Li
Journal:  J Exp Clin Cancer Res       Date:  2009-01-09

9.  Protein expression of eIF4E and integrin αvβ6 in colon cancer can predict clinical significance, reveal their correlation and imply possible mechanism of interaction.

Authors:  Zhengchuan Niu; Jiayong Wang; Shahbaz Muhammad; Weibo Niu; Enyu Liu; Cheng Peng; Benjia Liang; Qi Sun; Shinichi Obo; Zhaobin He; Song Liu; Xueqing Zou; Jun Niu
Journal:  Cell Biosci       Date:  2014-04-28       Impact factor: 7.133

10.  Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer.

Authors:  Rebecca A Millican-Slater; Craig D Sayers; Andrew M Hanby; Thomas A Hughes
Journal:  Br J Cancer       Date:  2016-06-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.